Success Metrics

Clinical Success Rate
90.9%

Based on 10 completed trials

Completion Rate
91%(10/11)
Active Trials
3(14%)
Results Posted
10%(1 trials)
Terminated
1(5%)

Phase Distribution

Ph phase_2
6
29%
Ph phase_1
1
5%
Ph phase_3
2
10%
Ph phase_4
7
33%
Ph not_applicable
5
24%

Phase Distribution

1

Early Stage

6

Mid Stage

9

Late Stage

Phase Distribution21 total trials
Phase 1Safety & dosage
1(4.8%)
Phase 2Efficacy & side effects
6(28.6%)
Phase 3Large-scale testing
2(9.5%)
Phase 4Post-market surveillance
7(33.3%)
N/ANon-phased studies
5(23.8%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

83.3%

10 of 12 finished

Non-Completion Rate

16.7%

2 ended early

Currently Active

3

trials recruiting

Total Trials

21

all time

Status Distribution
Active(4)
Completed(10)
Terminated(2)
Other(5)

Detailed Status

Completed10
unknown5
Recruiting3
Terminated1
Withdrawn1
Not yet recruiting1

Development Timeline

Analytics

Development Status

Total Trials
21
Active
3
Success Rate
90.9%
Most Advanced
Phase 4

Trials by Phase

Phase 11 (4.8%)
Phase 26 (28.6%)
Phase 32 (9.5%)
Phase 47 (33.3%)
N/A5 (23.8%)

Trials by Status

unknown524%
terminated15%
withdrawn15%
not_yet_recruiting15%
completed1048%
recruiting314%

Recent Activity

Clinical Trials (21)

Showing 20 of 21 trialsScroll for more
NCT06841536Not Applicable

Combined Effects of Statins and Exercise on Training Sensitive Health Markers

Completed
NCT04735263Phase 2

Dark Adaptation as an Early Indicator of Response to Statin Therapy for Intermediate AMD

Recruiting
NCT05567068Phase 2

Atorvastatin Efficacy and Safety in Patients With Ulcerative Colitis

Completed
NCT05561062Phase 2

Atorvastatin in Patients With Ulcerative Colitis

Completed
NCT06871358Not Applicable

The Effect of Atorvastatin 80 mg on Hs-CRP/Albumin Ratio in Reducing Thrombus Burden in PCI-STEMI Patients

Completed
NCT05792540Phase 2

Clinical Study to Evaluate the Possible Efficacy of Dapagliflozin and Atorvastatin in Patients With Major Depressive Disorders

Completed
NCT05076019Not Applicable

Statin Therapy With Atorvastatin in Surgical Aortic Valve Replacement

Recruiting
NCT06139952Phase 4

Ameliorating Contrast Induced Nephropathy After Coronary Angiography

Completed
NCT04347434Phase 4

Assessment of the Effects of Long-term Lipid-lowering Therapy in Patients With Primary STEMI or NSTEMI

Recruiting
NCT04900155Not Applicable

Evaluation of the Effect of Long-term Lipid-lowering Therapy in STEMI Patients With Coronavirus Infection COVID-19

Unknown
NCT03358017Phase 2

Neoadjuvant Zoledronate and Atorvastatin in Triple Negative Breast Cancer

Completed
NCT05912686Phase 4

High-Dose Atorvastatin for Vascular Wall Protection in Thrombectomy Patients

Not Yet Recruiting
NCT05103644Phase 2

Study of the Therapeutic Effect of Atorvastatin on the Clinical Outcomes in HER2 Negative Breast Cancer Patients"

Unknown
NCT04026230Phase 3

Impact of Atorvastatin on Prostate Cancer Progression During ADT

Unknown
NCT04974814Not Applicable

Effect of Statin Preloading in STEMI in Improving PCI Outcomes

Unknown
NCT01236430Phase 1

A Study to Determine the Bioequivalence of SCH 900068 Compared to Marketed Products (Protocol No. P07551)

Completed
NCT00457340Phase 4

Atorvastatin For The Reduction Of Ventricular Arrhythmias

Completed
NCT03750760Phase 4

Early Alirocumab to Reduce LDL-C in Myocardial Infarction

Withdrawn
NCT02901379Phase 3

Effect of 80-mg Atorvastatin on Myocardial Edema

Completed
NCT00344019Phase 4

Effects of Atorvastatin on Myonecrosis

Terminated

Drug Details

Intervention Type
DRUG
Total Trials
21